• 2024
  Leroux P, Matczak S, Bouchez V, Volant S, Ouziel A, Launay E, Faye A, Rabier V, Sarlangue J, Jeziorski E, Maakaroun-Vermesse Z, Madhi F, Pinquier D, Lorrot M, Pouletty M, Cantais A, Javouhey E, Aït Belghiti F, Guillot S, Rodrigues C, Brisse S, Cohen JF, Toubiana J, Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicenter study in France, 2008-2019., Clin Microbiol Infect 2024 Sep; (): .
• 2024
  Rodrigues C, Bouchez V, Soares A, Trombert-Paolantoni S, Aït El Belghiti F, Cohen JF, Armatys N, Landier A, Blanchot T, Hervo M, , Toubiana J, Brisse S, Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024., Euro Surveill 2024 Aug; 29(31): .
• 2023
  Soraya Matczak, Valérie Bouchez, Pauline Leroux, Thibaut Douché, Nils Collinet, Annie Landier, Quentin Giai Gianetto, Sophie Guillot, Julia Chamot-Rooke, Milena Hasan, Mariette Matondo, Sylvain Brisse, Julie Toubiana, Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype, Microbes and Infection, 2023, pp.105152. ⟨10.1016/j.micinf.2023.105152⟩.
• 2022
  Bridel S, Bouchez V, Brancotte B, Hauck S, Armatys N, Landier A, Mühle E, Guillot S, Toubiana J, Maiden MCJ, Jolley KA, Brisse S, , A comprehensive resource for Bordetella genomic epidemiology and biodiversity studies., Nat Commun 2022 Jul; 13(1): 3807.
• 2022
  Lefrancq N, Bouchez V, Fernandes N, Barkoff AM, Bosch T, Dalby T, Åkerlund T, Darenberg J, Fabianova K, Vestrheim DF, Fry NK, González-López JJ, Gullsby K, Habington A, He Q, Litt D, Martini H, Piérard D, Stefanelli P, Stegger M, Zavadilova J, Armatys N, Landier A, Guillot S, Hong SL, Lemey P, Parkhill J, Toubiana J, Cauchemez S, Salje H, Brisse S, , Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis., Sci Transl Med 2022 Apr; 14(642): eabn3253.
• 2021
  Bouchez V, Guillot S, Landier A, Armatys N, Matczak S, , Toubiana J, Brisse S, Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018., Euro Surveill 2021 Sep; 26(37): .
• 2021
  Badell E, Alharazi A, Criscuolo A, Almoayed KAA, Lefrancq N, Bouchez V, Guglielmini J, Hennart M, Carmi-Leroy A, Zidane N, Pascal-Perrigault M, Lebreton M, Martini H, Salje H, Toubiana J, Dureab F, Dhabaan G, Brisse S, Ongoing diphtheria outbreak in Yemen: a cross-sectional and genomic epidemiology study., Lancet Microbe 2021 Aug; 2(8): e386-e396.
• 2019
  Ben Fraj I, Bouchez V, Smaoui H, Kechrid A, Brisse S, , Genome characteristics of Bordetella pertussis isolates from Tunisia., J. Med. Microbiol. 2019 Sep; 68(9): 1320-1323.
• 2019
  Toubiana J, Azarnoush S, Bouchez V, Landier A, Guillot S, Matczak S, Bonacorsi S, Brisse S, , Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics., Open Forum Infect Dis 2019 Apr; 6(4): ofz122.
• 2018
  Ben Fraj I, Kechrid A, Guillot S, Bouchez V, Brisse S, Guiso N, Smaoui H, Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016, J. Med. Microbiol. 2019 Feb;68(2):241-247.
• 2018
  Bouchez V, Baines SL, Guillot S, Brisse S, Complete Genome Sequences of Bordetella pertussis Clinical Isolate FR5810 and Reference Strain Tohama from Combined Oxford Nanopore and Illumina Sequencing, Microbiol Resour Announc 2018 Nov;7(19).
• 2018
  Bouchez V, Guglielmini J, Dazas M, Landier A, Toubiana J, Guillot S, Criscuolo A, Brisse S, Genomic Sequencing of Bordetella pertussis for Epidemiology and Global Surveillance of Whooping Cough, Emerging Infect. Dis. 2018 Jun;24(6):988-994.
• 2017
  Otsuka N, Guiso N, Bouchez V, The length of poly(C) stretch in the Bordetella pertussis Pfim3 promoter determines the vag or vrg function of the fim3 gene, Microbiology (Reading, Engl.) 2017 Sep;163(9):1364-1368.
• 2017
  Bouchez V, AlBitar-Nehmé S, Novikov A, Guiso N, Caroff M, Bordetella holmesii: Lipid A Structures and Corresponding Genomic Sequences Comparison in Three Clinical Isolates and the Reference Strain ATCC 51541, Int J Mol Sci 2017 May;18(5).
• 2015
  Bouchez V, Hegerle N, Strati F, Njamkepo E, Guiso N, New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates, Vaccines (Basel) 2015;3(3):751-70.
• 2015
  Bouchez V, Guiso N, Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough, Pathog Dis 2015 Oct;73(7).
• 2015
  Basheer SM, Bouchez V, Novikov A, Augusto LA, Guiso N, Caroff M, Structure activity characterization of Bordetella petrii lipid A, from environment to human isolates, Biochimie 2016 Jan;120:87-95.
• 2014
  van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N, Wirsing von Kőnig CH, Vestrheim DF, Dalby T, Fry NK, Pierard D, Detemmerman L, Zavadilova J, Fabianova K, Logan C, Habington A, Byrne M, Lutyńska A, Mosiej E, Pelaz C, Gröndahl-Yli-Hannuksela K, Barkoff AM, Mertsola J, Economopoulou A, He Q, Mooi FR, Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012, Eur. J. Clin. Microbiol. Infect. Dis. 2015 Apr;34(4):821-30.
• 2014
  Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR, Global population structure and evolution of Bordetella pertussis and their relationship with vaccination, MBio 2014;5(2):e01074.
• 2013
  Valérie Bouchez, Nicole Guiso, Bordetella holmesii: Comparison of Two Isolates from Blood and a Respiratory Sample, V. Bouchez and N. Guiso, "Bordetella holmesii: Comparison of Two Isolates from Blood and a Respiratory Sample," Advances in Infectious Diseases, Vol. 3 No. 2, 2013, pp. 123-133. doi: 10.4236/aid.2013.32020..
• 2011
  Bouchez V, Brun D, Dore G, Njamkepo E, Guiso N, Bordetella parapertussis isolates not expressing pertactin circulating in France, Clin. Microbiol. Infect. 2011 May;17(5):675-82.
• 2009
  Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N, First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin, Vaccine 2009 Oct;27(43):6034-41.
• 2008
  Bouchez V, Caro V, Levillain E, Guigon G, Guiso N, Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination, PLoS ONE 2008;3(6):e2437.
• 2008
  Caro V, Bouchez V, Guiso N, Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?, J. Clin. Microbiol. 2008 Jun;46(6):2125-8.
• 2006
  Caro V, Bouchez V, Guiso N, Gatti B, Agosti MR, Ayala SE, Pertussis in Argentina and France, Vaccine 2007 May;25(22):4335-9.
• 2003
  Jean-Philippe, P.Delgenes, Valerie Penaud, René Moletta, Pretreatments for the enhancement of anaerobic digestion of solid wastes, Book "Biomethanization of the organic fraction of municipal solid wastes " Edited by J. Mata-Alvarez, published by IWA..
• 2000
  Delgenès JP, Penaud V, Torrijos M, Moletta R, Investigations on the changes in anaerobic biodegradability and biotoxicity of an industrial microbial biomass induced by a thermochemical pretreatment, Water Sci. Technol. 2000;41(3):137-44.
• 2000
  Valérie Penaud; Jean-Philippe Delgenès; and René Moletta , Characterization of soluble molecules from thermochemically pretreated sludge, J ENV ENG, 126(5), 2000, pp. 397-402.
• 2000
  Penaud, V; Delgenes, JP; Moletta, R, Influence of thermochemical pretreatment conditions on solubilization and anaerobic biodegradability of a microbial biomass, ENV TECHNOL, 21(1), 2000, pp. 87-96.
• 1999
  Penaud, V; Delgenes, JP; Moletta, R , Thermo-chemical pretreatment of a microbial biomass: influence of sodium hydroxide addition on solubilization and anaerobic biodegradability, ENZYME MICR, 25(3-5), 1999, pp. 258-263.
• 1997
  PENAUD V; DELGENES JP; TORRIJOS M; MOLETTA R; VANHOUTTE B; CANS P , DEFINITION OF OPTIMAL CONDITIONS FOR THE HYDROLYSIS AND ACIDOGENESIS OF A PHARMACEUTICAL MICROBIAL BIOMASS, Process biochemistry, 32(6), 1997, pp. 515-521.